BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/8/2021 10:51:03 AM | Browse: 574 | Download: 1071
 |
Received |
|
2021-02-05 15:14 |
|
Peer-Review Started |
|
2021-02-05 15:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-29 01:31 |
|
Revised |
|
2021-04-03 12:36 |
|
Second Decision |
|
2021-05-22 14:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-22 15:25 |
|
Articles in Press |
|
2021-05-22 15:25 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-02 03:27 |
|
Publish the Manuscript Online |
|
2021-06-08 10:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Frontier |
| Article Title |
Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Magdy El-Salhy, Tanisa Patcharatrakul and Sutep Gonlachanvit |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Helse Fonna |
40415 |
|
| Corresponding Author |
Magdy El-Salhy, BSc, MD, PhD, Chief Doctor, Professor, Department of Medicine, Stord Helse Fonna Hospital and University of Bergen, Tysevegen 64, Stord 5416, Norway. magdy.elsalhy@sklbb.no |
| Key Words |
Butyric acid; Enteroendocrine cells; Etiology; Microbiota; Short-chain fatty acids; Superdonor; Therapy |
| Core Tip |
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. There is no effective treatment for IBS, but fecal microbiota transplantation (FMT) seems promising. Some randomized controlled trials (RCTs) have shown that FMT improved the symptoms and quality of life of IBS patients, but others have found no such effects. The discrepancies between the outcomes of these RCTs are due to the selection processes for the donor and treated patients, the dose of transplant used, and the route of administration. Further studies are needed to optimize the FMT conditions in IBS patients. |
| Publish Date |
2021-06-08 10:51 |
| Citation |
El-Salhy M, Patcharatrakul T, Gonlachanvit S. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century. World J Gastroenterol 2021; 27(22): 2921-2943 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i22/2921.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i22.2921 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
